Lorcaserin Effects on Cocaine Craving and Drug-Reinforced Behavior

氯卡色林对可卡因渴望和药物强化行为的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): Background Serotonin (5-HT) is one of three monoamines that are widely distributed in the brain and play important roles in affect and goal-directed behaviors. Limbic structures that underlie behavior motivated by palatable food and drugs of abuse receive dense projections from brainstem serotonergic nuclei. In rats, light and sound cues associated with access to cocaine strongly stimulate drug-seeking behavior. Agonists for the type 2C serotonergic receptor (5-HT2CR) attenuate this responding. Drug taking (cocaine self-administration) is also attenuated at 5-HT2CR agonist doses similar to those that decrease food-reinforced responding and cause reductions in locomotor activity. Lorcaserin is a novel and selective agonist of the 5-HT2CR recently approved by the FDA for weight loss therapy. It acts selectively at this receptor subtype with minimal activation of 5-HT2AR or 5-HT2BR receptors. Based on initial clinical studies leading to its approval, lorcaserin is well tolerated and probably does not cause cardiac valve disease or other serious side effects. Rationale In preclinical studies, agonists for the 5-HT2CR potently attenuate cocaine-seeking behavior. Lorcaserin is a recently approved selective 5-HT2CR agonist with an acceptable safety profile in humans. No studies have reported its effects on cocaine-induced craving or drug-reinforced responding in humans. Specific Aims: 1. Determine whether lorcaserin pretreatment attenuates the positive subjective effects of cocaine and drug- reinforced behavior. 2. Evaluate whether active treatment modifies cocaine- or script- induced craving. 3. Characterize the bioavailability of lorcaserin in individual participants and determine whether it modifies plasma levels of cocaine. Methods This is a randomized, cross-over, double-blind, placebo-controlled, research-unit, single-center, multiple-panel evaluation of the potential for oral lorcaserin to modify craving and cocaine self-administration in a laboratory setting. A total of 24 non-treatment-seeking, regular cocaine users will receive pretreatment with single doses of oral placebo, lorcaserin 10 mg (panel 1), or lorcaserin 20 mg (panel 2). Script-guided imagery of autobiographical memories will be developed based on experiences related to cocaine use, anger, and a neutral event. Following treatment with lorcaserin, script-induced emotional states will be assayed. Sampling doses of cocaine (0.0, 0.23, and 0.46 mg/kg) will be administered, and participants will choose between self- administering additional intravenous doses or receiving monetary alternatives. Detailed measures of the negative and positive subjective effects of intravenous infusions will also be made. As noncontingent infusions of cocaine are administered, the pharmacokinetics of cocaine and lorcaserin will be determined.
5-羟色胺(5-HT)是广泛分布于大脑中的三种单胺之一,在情感和目标导向行为中起重要作用。由美味食物和滥用药物引起的行为背后的边缘结构受到脑干血清素能核的密集投射。在老鼠身上,与获得可卡因有关的光和声音线索强烈地刺激了寻求毒品的行为。2C型血清素能受体(5-HT2CR)的激动剂减弱了这种反应。5-HT2CR激动剂的剂量与那些减少食物强化反应和导致运动活动减少的药物剂量相似,药物服用(可卡因自我给药)也会减弱。氯卡色林是一种新型的选择性5-HT2CR激动剂,最近被FDA批准用于减肥治疗。它选择性地作用于5-HT2AR或5-HT2BR受体亚型。根据初步临床研究,氯卡色林耐受性良好,可能不会引起心脏瓣膜疾病或其他严重的副作用。在临床前研究中,5-HT2CR激动剂能有效减弱可卡因寻求行为。氯卡色林是最近批准的选择性5-HT2CR激动剂,在人类中具有可接受的安全性。没有研究报告它对人类可卡因诱导的渴望或药物强化反应的影响。具体目标:1;确定氯卡色林预处理是否会减弱可卡因和药物强化行为的积极主观效应。2. 评估积极治疗是否能改变可卡因或剧本引起的渴望。3. 描述氯卡色林在个体参与者中的生物利用度并确定

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KENNETH W. GRASING其他文献

KENNETH W. GRASING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KENNETH W. GRASING', 18)}}的其他基金

Translating Melatonin- and Serotonin-2C Interactions into Improved Treatments for Pain and Opioid-Use Disorders
将褪黑素和血清素 2C 的相互作用转化为疼痛和阿片类药物使用障碍的改进治疗方法
  • 批准号:
    10515318
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
Translating Melatonin- and Serotonin-2C Interactions into Improved Treatments for Pain and Opioid-Use Disorders
将褪黑素和血清素 2C 的相互作用转化为疼痛和阿片类药物使用障碍的改进治疗方法
  • 批准号:
    10045505
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
Translating Melatonin- and Serotonin-2C Interactions into Improved Treatments for Pain and Opioid-Use Disorders
将褪黑素和血清素 2C 的相互作用转化为疼痛和阿片类药物使用障碍的改进治疗方法
  • 批准号:
    10292939
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
Lorcaserin Effects on Cocaine Craving and Drug-Reinforced Behavior
氯卡色林对可卡因渴望和药物强化行为的影响
  • 批准号:
    8918564
  • 财政年份:
    2014
  • 资助金额:
    $ 18.75万
  • 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
  • 批准号:
    8244379
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
  • 批准号:
    8774152
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
  • 批准号:
    8598009
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
  • 批准号:
    8413391
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetic Measures
他克林对可卡因自我给药的影响和药代动力学测量
  • 批准号:
    8278546
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetic Measures
他克林对可卡因自我给药的影响和药代动力学测量
  • 批准号:
    8113822
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了